Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Heparin sodium + allantoin + onion extract gel is a topical combination therapy widely used for the management and prevention of hypertrophic scars, keloids, and other types of pathological scarring resulting from surgery, burns, or trauma. The formulation typically contains three active ingredients: **heparin sodium**, which exerts anti-inflammatory and anti-proliferative effects by inhibiting fibroblast growth and promoting tissue hydration; **allantoin**, which facilitates wound healing, provides keratolytic effects to soften the scar tissue, and increases water-binding capacity; and **onion extract** (Extractum Cepae), which contributes additional anti-inflammatory properties and inhibits excessive collagen synthesis. Together, these components work synergistically to flatten scars, reduce redness, and alleviate symptoms such as itching and tension. It is often used as a standard-of-care topical treatment in clinical settings and has been evaluated in combination with other modalities, such as 5-fluorouracil and microneedle-assisted delivery systems.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on heparin sodium + allantoin + onion extract.